Dan Hu Selected Research

asperterpenoid A

1/2019

Biosynthesis of an anti-tuberculosis sesterterpenoid asperterpenoid A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dan Hu Research Topics

Disease

47	Neoplasms (Cancer) 10/2022 - 01/2006
13	Brugada Syndrome 12/2021 - 11/2006
11	Infections 01/2022 - 04/2013
11	Myocardial Infarction 01/2021 - 10/2008
10	Cardiac Arrhythmias (Arrythmia) 07/2017 - 01/2012
9	Atrial Fibrillation 01/2022 - 01/2012
9	Heart Failure 01/2022 - 01/2012
9	Stomach Neoplasms (Stomach Cancer) 01/2021 - 12/2016
9	Inflammation (Inflammations) 01/2021 - 01/2012
8	Hypoxia (Hypoxemia) 11/2019 - 01/2007
8	Ischemia 04/2017 - 08/2007
7	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 01/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2017
5	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2010
5	Carcinogenesis 01/2022 - 01/2013
5	Fibrosis (Cirrhosis) 12/2020 - 01/2013
5	Parkinson Disease (Parkinson's Disease) 12/2018 - 12/2007
4	Wounds and Injuries (Trauma) 09/2022 - 05/2005
4	Carcinoma (Carcinomatosis) 01/2021 - 12/2016
4	Sepsis (Septicemia) 07/2019 - 06/2015
4	Hyperglycemia 01/2019 - 02/2016
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2017
4	Bradycardia 01/2019 - 01/2013
4	Neoplasm Metastasis (Metastasis) 10/2018 - 01/2007
4	Ventricular Tachycardia 01/2017 - 08/2008
4	Choroidal Neovascularization 03/2012 - 01/2007
3	Lymphatic Metastasis 10/2022 - 01/2016
3	Glaucoma 09/2022 - 09/2021
3	Fever (Fevers) 01/2022 - 01/2016
3	Ischemic Stroke 03/2021 - 01/2016
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021 - 10/2017
3	COVID-19 01/2021 - 06/2020
3	Hypertension (High Blood Pressure) 01/2021 - 01/2017
3	Rheumatoid Arthritis 12/2020 - 06/2015
3	Thrombosis (Thrombus) 06/2020 - 05/2016
3	HIV Infections (HIV Infection) 10/2019 - 01/2018
3	Diabetes Mellitus 06/2019 - 01/2018
3	Genetic Predisposition to Disease (Genetic Predisposition) 06/2019 - 04/2012
3	Hemorrhage 03/2019 - 12/2013
3	Short Qt Syndrome 01/2019 - 05/2011
3	Ventricular Fibrillation 01/2017 - 01/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 06/2016 - 01/2006
3	Hepatocellular Carcinoma (Hepatoma) 04/2015 - 07/2006
2	Glioma (Gliomas) 09/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2022 - 11/2012
2	Cardiotoxicity 01/2022 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2007
2	Nasopharyngeal Carcinoma 01/2022 - 01/2021
2	Bites and Stings (Sting) 01/2022 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 06/2021 - 03/2008
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 10/2022 - 05/2004
14	Sodium Channels (Sodium Channel)IBA 12/2021 - 11/2006
13	Biomarkers (Surrogate Marker)IBA 03/2022 - 12/2015
10	Pharmaceutical PreparationsIBA 01/2020 - 01/2012
10	Messenger RNA (mRNA)IBA 01/2019 - 07/2006
9	Biological ProductsIBA 01/2022 - 02/2016
6	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 07/2016 - 11/2008
5	CytokinesIBA 03/2021 - 06/2015
5	LipidsIBA 01/2021 - 01/2017
5	CalciumIBA 01/2021 - 01/2012
5	Blood Glucose (Blood Sugar)IBA 01/2020 - 10/2016
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 12/2015
4	SodiumIBA 01/2020 - 01/2012
4	salicylhydroxamic acid (SHAM)IBA 01/2020 - 01/2014
4	Glucose (Dextrose)FDA LinkGeneric 06/2019 - 04/2012
4	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2013
3	ApelinIBA 10/2022 - 01/2017
3	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2021
3	AntibodiesIBA 01/2022 - 12/2017
3	VaccinesIBA 01/2022 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020 - 01/2007
3	1- (3,5- bis- trifluoromethylphenyl)- 3- (2,4- dibromo- 6- (1H- tetrazol- 5- yl)phenyl)ureaIBA 01/2020 - 04/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2017
3	CholesterolIBA 04/2019 - 01/2018
3	ElectrolytesIBA 01/2019 - 11/2017
3	Long Noncoding RNAIBA 12/2018 - 12/2016
3	NF-kappa B (NF-kB)IBA 01/2018 - 03/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 05/2013
3	Hematoxylin (Haematoxylon)IBA 10/2017 - 08/2007
3	Eosine Yellowish-(YS) (Eosin)IBA 10/2017 - 08/2007
3	wenxin keliIBA 03/2016 - 01/2012
2	Fluorouracil (Carac)FDA LinkGeneric 03/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
2	SA 4503IBA 01/2022 - 01/2019
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 01/2020
2	Sigma-1 ReceptorIBA 01/2022 - 01/2019
2	Immune Checkpoint InhibitorsIBA 12/2021 - 10/2017
2	Coloring Agents (Dyes)IBA 12/2021 - 01/2020
2	AndrogensIBA 06/2021 - 03/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2021 - 01/2018
2	CC chemokine receptor 9IBA 01/2021 - 01/2016

Therapy/Procedure

16	Therapeutics 09/2021 - 01/2006
7	Immunotherapy 01/2022 - 01/2018
7	Qigong (Qi Gong) 06/2021 - 01/2006
6	Gastrectomy 12/2018 - 01/2017
4	Punctures 07/2019 - 06/2015
4	Ligation 07/2019 - 06/2015
3	Radiotherapy 12/2020 - 01/2018
2	Lasers (Laser) 09/2022 - 01/2011